Projects per year
Personal profile
Research interests
Miller Lab Consortium. To date, our team has treated more than 400 patients with natural killer cell infusions and over a hundred patients with therapies that activate their own natural killer cells. We've retrospectively analyzed more than 5000 patients and enrolled more than 500 patients in prospective trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
- 8 Similar Profiles
Collaborations and top research areas from the last five years
-
A Phase 1, First-in-Human Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Participants With Prostate Cancer
Zorko, N. A. (PI)
5/6/26 → 5/31/36
Project: Research project
-
An Open-label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-3028 in Patients with Castration Resistant Prostate Cancer (CRPC)
Zorko, N. A. (PI)
12/10/25 → 12/9/36
Project: Research project
-
A Phase 3 Randomized, Double-blind, Placebo-controlled Study of Pasritamig (JNJ-78278343), a T-cell-redirecting Agent Targeting Human Kallikrein 2, + Best Supportive Care Versus Best Supportive Care for Metastatic Castration-resistant Prostate Cancer
Zorko, N. A. (PI)
JANSSEN RESEARCH & DEVELOPMENT, LLC
6/25/25 → 6/29/29
Project: Research project
-
# Integrated Single-Cell Profiling Reveals Dichotomous NK Cell Populations Associated with Immunosuppression in Solid Tumors
Lozada, J. R., Ali, A., Luo, C., Plagens, R. N., Zhang, B., Elliott, A., Boytim, E., Zorko, N. A., Heath, E. I., Patnaik, A., Vanderwalde, A. M., Antonarakis, E. S., Miller, J. S., Hwang, J. H. & Cichocki, F., Jun 1 2026, In: Cancer Immunology Research. 14, 6, p. 1008-1021 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer
Hudson, A., Jayaram, A., Garmezy, B., Zorko, N. A., Zarrabi, K. K., Mathews, L., Rupnow, B., Li, M., Ghosh, D., Urtishak, K., Francis, P., Wang, S. C., Attiyeh, E. & de Bono, J., Dec 2026, In: Cancer chemotherapy and pharmacology. 96, 1, 5.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer
Makovec, A., Gustafson, A. P., Gandhi, N., Rampalli, S., Arafa, A. T., Elliott, A., Smith, N., Felices, M., Kennedy, P. R., Shenderov, E., Patnaik, A., Narayan, V., Heath, E. I., Zorko, N. A., Shi, X., Antonarakis, E. S., McKay, R. R. & Hwang, J., Aug 1 2026, In: Clinical Cancer Research. 32, 15, p. 3381-3394 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Case of complete response to immunotherapy in MMR-deficient prostate cancer associated with NK-like and CD4+CD8+ T cells
Tsai, A. K., Lozada, J. R., Kennedy, P. R., Moline, D., Pandey, R., Lyons, R. C., Luo, C., Wang, R., Arafa, A. T., Femino, E. L., Zipkowitz, S., Figueroa, A., McCann, P. J., Dallos, M. C., Elliott, A., Murugan, P., Felices, M., Zorko, N. A., Konety, B. R. & Dehm, S. M. & 7 others, , Jul 21 2026, In: Cell Reports Medicine. 7, 7, 102889.Research output: Contribution to journal › Article › peer-review
Open Access -
HLA class I expression shapes the tumor immune microenvironment and influences prognosis in prostate cancer
Likasitwatanakul, P., Besonen, C., Tsai, A. K., Sadeghipour, N., Elliott, A., Arafa, A. T., Passow, R., Chesner, L., Felices, M., Kennedy, P. R., Patnaik, A., Narayan, V., Hamrick, J., Sena, L. A., Zorko, N. A., Hwang, J. H. & Antonarakis, E. S., Jun 2026, In: Prostate Cancer and Prostatic Diseases. 29, 2, p. 425-434 10 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations